Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Shares in Denmark's pharmaceutical giant Novo Nordisk (NYSE: NVO) were lower by 4% as of 11 a.m. ET today. The move comes as ...

Novo Nordisk has been actively pursuing licensing deals over the past six months. There are other good reasons to consider ...

The NNF – a philanthropic non-profit organisation that owns a controlling stake in Danish drugmaker Novo Nordisk – has been ...

However, negotiations for the EU's pharmaceutical legislation – dubbed the pharma package – were complex, particularly as ...

Amycretin is a unimolecular long-acting GLP-1 and amylin receptor agonist under development by Novo Nordisk, to provide an ...

Raise awareness of obesity as a chronic, multifactorial disease. Reduce stigma and myths that hinder early care. Encourage ...

Novo Nordisk is gearing up for its largest-ever corporate summer party, inviting employees to the Animal Fairgrounds in Roskilde on August 22. The pharmaceutical company expects more than 20,000 ...

Mumbai: Novo Nordisk, a global healthcare company headquartered in Denmark, has announced the launch of Wegovy (injectable ...

Eli Lilly said on Thursday India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...

Novo Nordisk launches Wegovy, its anti-obesity drug, in India. Targeting a large obese population, Wegovy aims to improve ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...